Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Nose-to-brain delivery of transferrin-modified carmustine-loaded iron nanoparticles for enhanced glioblastoma treatment76
Polymyxin B delivery systems: smart solutions for improved antibacterial activity and reduced toxicity61
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma49
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma44
Advancement in transporter-oriented nanoplatforms for cancer therapy43
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances38
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches36
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis33
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes31
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells31
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer29
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases29
Beyond drug delivery: nanoparticles as active modulators of immunometabolism for treating inflammatory diseases28
Correction28
Improved antidiabetic potential of quercetin-loaded chitosan–lecithin nanoparticles for effective glycaemic control26
Emerging role of ferroptosis in diabetic retinopathy: a review26
Chitosan–β-glycerophosphate thermogelling microneedles for transdermal contraceptive delivery of levonorgestrel25
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice24
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer24
Interactions and communications in lung tumour microenvironment: chemo/radiotherapy resistance mechanisms and therapeutic targets23
Engineered extracellular vesicle with RAGE-antagonist peptide for delivery of anti-miRNA155 oligonucleotides to inflammatory lung cells23
Ferroptosis-targeting drugs in breast cancer23
Absorption enhancer approach for protein delivery by various routes of administration: a rapid review23
The role of MSC-derived exosomes in immune modulation and regenerative medicine23
Correction23
1.4132149219513